Cargando…
The Role of Gene Therapy in Premature Ovarian Insufficiency Management
Premature ovarian insufficiency (POI) is a highly prevalent disorder, characterized by the development of menopause before the age of 40. Most cases are idiopathic; however, in some women the cause of this condition (e.g.; anticancer treatment, genetic disorders, and enzymatic defects) could be iden...
Autores principales: | Atabiekov, Ihor, Hobeika, Elie, Sheikh, Ujalla, El Andaloussi, Abdeljabar, Al-Hendy, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316312/ https://www.ncbi.nlm.nih.gov/pubmed/30388808 http://dx.doi.org/10.3390/biomedicines6040102 |
Ejemplares similares
-
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature
por: Igboeli, Prosper, et al.
Publicado: (2020) -
Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells
por: Park, Hang-Soo, et al.
Publicado: (2019) -
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model
por: Park, Hang-soo, et al.
Publicado: (2021) -
Intravenous Infusion of Nucleated Peripheral Blood Cells Restores Fertility in Mice with Chemotherapy-Induced Premature Ovarian Failure
por: El Andaloussi, Abdeljabar, et al.
Publicado: (2018) -
Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency
por: Ulin, Mara, et al.
Publicado: (2021)